U.S. markets closed

CRH Medical Corporation (CRHM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
3.9900+0.0200 (+0.50%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close3.9700
Open3.9700
Bid3.9900 x 3000
Ask4.0000 x 2900
Day's Range3.9700 - 4.0000
52 Week Range1.6600 - 4.0000
Volume509,501
Avg. Volume1,188,248
Market Cap285.768M
Beta (5Y Monthly)3.11
PE Ratio (TTM)N/A
EPS (TTM)-0.3420
Earnings DateMar 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • CRH Medical Securityholders Approve Acquisition by WELL Health
    CNW Group

    CRH Medical Securityholders Approve Acquisition by WELL Health

    CRH Medical Corporation (TSX: CRH) (NYSE: CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today.

  • CRH Medical Corporation Updates Special Meeting Materials in Connection with Proposed Arrangement with Well Health Technologies Corp.
    CNW Group

    CRH Medical Corporation Updates Special Meeting Materials in Connection with Proposed Arrangement with Well Health Technologies Corp.

    CRH Medical Corporation (TSX: CRH) (NYSE American: CRHM) ("CRH" or the "Company") announced today that it has filed with the U.S. Securities and Exchange Commission (the "SEC") a Current Report on Form 8-K containing certain disclosures that are intended to amend and supplement the Company's proxy statement and management information circular, dated March 19, 2021 (the "Circular"), relating to the special meeting of CRH securityholders that will be held in connection with the proposed acquisition of CRH by WELL Health Technologies Corp. (the "Arrangement"), which Circular was previously mailed to securityholders. The Current Report and supplemental disclosures are available on the SEC's website at http://www.sec.gov, on SEDAR at www.sedar.com and on the Company's website at http://investors.crhsystem.com.

  • CRH Medical Corporation Announces Purchase of Remaining Ownership in Lake Lanier Anesthesia Associates
    CNW Group

    CRH Medical Corporation Announces Purchase of Remaining Ownership in Lake Lanier Anesthesia Associates

    CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has completed an accretive transaction whereby the Company has acquired the remaining 25% interest in Lake Lanier Anesthesia Associates ("LLAA") a gastroenterology anesthesia practice located in Georgia. CRH initially acquired 75% of LLAA in June of 2020.This transaction will increase adjusted operating EBITDA attributable to shareholders, as CRH now owns 100% of LLAA. This transaction was financed through a combination of CRH's credit facility and cash on hand.